Your browser doesn't support javascript.
loading
Variability in Expression of CYP3A5 in Human Fetal Liver.
Vyhlidal, Carrie A; Pearce, Robin E; Gaedigk, Roger; Calamia, Justina C; Shuster, Diana L; Thummel, Kenneth E; Leeder, J Steven.
Afiliación
  • Vyhlidal CA; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri (C.A.V., R.E.P., R.G., J.S.L.); Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington (J.C.C., D.L.S., K.E.T.)
  • Pearce RE; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri (C.A.V., R.E.P., R.G., J.S.L.); Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington (J.C.C., D.L.S., K.E.T.)
  • Gaedigk R; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri (C.A.V., R.E.P., R.G., J.S.L.); Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington (J.C.C., D.L.S., K.E.T.)
  • Calamia JC; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri (C.A.V., R.E.P., R.G., J.S.L.); Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington (J.C.C., D.L.S., K.E.T.)
  • Shuster DL; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri (C.A.V., R.E.P., R.G., J.S.L.); Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington (J.C.C., D.L.S., K.E.T.)
  • Thummel KE; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri (C.A.V., R.E.P., R.G., J.S.L.); Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington (J.C.C., D.L.S., K.E.T.)
  • Leeder JS; Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children's Mercy Hospital, Kansas City, Missouri (C.A.V., R.E.P., R.G., J.S.L.); Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington (J.C.C., D.L.S., K.E.T.)
Drug Metab Dispos ; 43(8): 1286-93, 2015 Aug.
Article en En | MEDLINE | ID: mdl-25979262
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Citocromo P-450 CYP3A / Feto / Hígado Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Drug Metab Dispos Asunto de la revista: FARMACOLOGIA Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Citocromo P-450 CYP3A / Feto / Hígado Tipo de estudio: Risk_factors_studies Límite: Adult / Female / Humans / Pregnancy Idioma: En Revista: Drug Metab Dispos Asunto de la revista: FARMACOLOGIA Año: 2015 Tipo del documento: Article